Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Correction to: NSAID use and somatic exomic mutations in Barrett's esophagus.

Galipeau PC, Oman KM, Paulson TG, Sanchez CA, Zhang Q, Marty JA, Delrow JJ, Kuhner MK, Vaughan TL, Reid BJ, Li X.

Genome Med. 2019 Mar 12;11(1):14. doi: 10.1186/s13073-019-0625-y.

2.

NSAID use and somatic exomic mutations in Barrett's esophagus.

Galipeau PC, Oman KM, Paulson TG, Sanchez CA, Zhang Q, Marty JA, Delrow JJ, Kuhner MK, Vaughan TL, Reid BJ, Li X.

Genome Med. 2018 Feb 27;10(1):17. doi: 10.1186/s13073-018-0520-y. Erratum in: Genome Med. 2019 Mar 12;11(1):14.

3.

Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels.

Martinez P, Mallo D, Paulson TG, Li X, Sanchez CA, Reid BJ, Graham TA, Kuhner MK, Maley CC.

Nat Commun. 2018 Feb 23;9(1):794. doi: 10.1038/s41467-017-02621-x.

4.

Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data.

Cheng Y, Dai JY, Paulson TG, Wang X, Li X, Reid BJ, Kooperberg C.

Ann Appl Stat. 2017 Jun;11(2):967-991. doi: 10.1214/17-AOAS1026. Epub 2017 Jul 20.

5.

Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.

Paulson TG.

Adv Exp Med Biol. 2016;908:213-36. doi: 10.1007/978-3-319-41388-4_11.

PMID:
27573774
6.

Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Reid BJ, Paulson TG, Li X.

Gastroenterology. 2015 Oct;149(5):1142-1152.e3. doi: 10.1053/j.gastro.2015.07.010. Epub 2015 Jul 21. Review.

7.

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.

Li X, Paulson TG, Galipeau PC, Sanchez CA, Liu K, Kuhner MK, Maley CC, Self SG, Vaughan TL, Reid BJ, Blount PL.

Cancer Prev Res (Phila). 2015 Sep;8(9):845-56. doi: 10.1158/1940-6207.CAPR-15-0130. Epub 2015 Jun 30.

8.

Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays.

Kissel HD, Paulson TG, Liu K, Li X, Swisher E, Garcia R, Sanchez CA, Reid BJ, Reed SD, Doherty JA.

Obstet Gynecol Int. 2013;2013:576842. doi: 10.1155/2013/576842. Epub 2013 Oct 26.

9.

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.

Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL, Reid BJ.

Cancer Prev Res (Phila). 2014 Jan;7(1):114-27. doi: 10.1158/1940-6207.CAPR-13-0289. Epub 2013 Nov 19.

10.

NSAIDs modulate clonal evolution in Barrett's esophagus.

Kostadinov RL, Kuhner MK, Li X, Sanchez CA, Galipeau PC, Paulson TG, Sather CL, Srivastava A, Odze RD, Blount PL, Vaughan TL, Reid BJ, Maley CC.

PLoS Genet. 2013 Jun;9(6):e1003553. doi: 10.1371/journal.pgen.1003553. Epub 2013 Jun 13.

11.

Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria.

Suchorolski MT, Paulson TG, Sanchez CA, Hockenbery D, Reid BJ.

PLoS One. 2013;8(2):e56884. doi: 10.1371/journal.pone.0056884. Epub 2013 Feb 27.

12.

Method for physiologic phenotype characterization at the single-cell level in non-interacting and interacting cells.

Kelbauskas L, Ashili SP, Houkal J, Smith D, Mohammadreza A, Lee KB, Forrester J, Kumar A, Anis YH, Paulson TG, Youngbull CA, Tian Y, Holl MR, Johnson RH, Meldrum DR.

J Biomed Opt. 2012 Mar;17(3):037008. doi: 10.1117/1.JBO.17.3.037008.

13.

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.

Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ.

Clin Cancer Res. 2009 May 15;15(10):3305-14. doi: 10.1158/1078-0432.CCR-08-2494. Epub 2009 May 5.

14.

p16 mutation spectrum in the premalignant condition Barrett's esophagus.

Paulson TG, Galipeau PC, Xu L, Kissel HD, Li X, Blount PL, Sanchez CA, Odze RD, Reid BJ.

PLoS One. 2008;3(11):e3809. doi: 10.1371/journal.pone.0003809. Epub 2008 Nov 27.

15.

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Chao DL, Sanchez CA, Galipeau PC, Blount PL, Paulson TG, Cowan DS, Ayub K, Odze RD, Rabinovitch PS, Reid BJ.

Clin Cancer Res. 2008 Nov 1;14(21):6988-95. doi: 10.1158/1078-0432.CCR-07-5063.

16.

Direct inference of SNP heterozygosity rates and resolution of LOH detection.

Li X, Self SG, Galipeau PC, Paulson TG, Reid BJ.

PLoS Comput Biol. 2007 Nov;3(11):e244.

17.

Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.

Lai LA, Paulson TG, Li X, Sanchez CA, Maley C, Odze RD, Reid BJ, Rabinovitch PS.

Genes Chromosomes Cancer. 2007 Jun;46(6):532-42.

PMID:
17330261
18.

Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.

Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1935-40.

19.

Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues.

Kraly JR, Jones MR, Gomez DG, Dickerson JA, Harwood MM, Eggertson M, Paulson TG, Sanchez CA, Odze R, Feng Z, Reid BJ, Dovichi NJ.

Anal Chem. 2006 Sep 1;78(17):5977-86.

20.

Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ.

Nat Genet. 2006 Apr;38(4):468-73. Epub 2006 Mar 26.

PMID:
16565718
21.

Neosquamous epithelium does not typically arise from Barrett's epithelium.

Paulson TG, Xu L, Sanchez C, Blount PL, Ayub K, Odze RD, Reid BJ.

Clin Cancer Res. 2006 Mar 15;12(6):1701-6.

22.

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.

Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Blount PL, Reid BJ.

Cancer Res. 2004 Oct 15;64(20):7629-33.

23.

Focus on Barrett's esophagus and esophageal adenocarcinoma.

Paulson TG, Reid BJ.

Cancer Cell. 2004 Jul;6(1):11-6. Review. No abstract available.

24.

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.

Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ.

Cancer Res. 2004 May 15;64(10):3414-27.

25.

Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.

Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG, Feng Z, Rabinovitch PS.

Carcinogenesis. 2003 Jul;24(7):1183-90. Epub 2003 May 9.

26.

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, Reid BJ.

Cancer Res. 2001 Nov 15;61(22):8284-9.

27.
28.

Evolution of neoplastic cell lineages in Barrett oesophagus.

Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ.

Nat Genet. 1999 May;22(1):106-9.

29.
30.

Maintaining genetic stability through TP53 mediated checkpoint control.

Wahl GM, Linke SP, Paulson TG, Huang LC.

Cancer Surv. 1997;29:183-219. Review.

PMID:
9338102
31.

Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer.

Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM.

Cancer Res. 1996 Sep 1;56(17):4021-6.

32.

Genetic instability as a consequence of inappropriate entry into and progression through S-phase.

Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM.

Cancer Metastasis Rev. 1995 Mar;14(1):59-73. Review.

PMID:
7606822

Supplemental Content

Loading ...
Support Center